Amarin | AMRN - C/Z Cena do Zysku





Pe Zmiana Data
AbbVie 23.96 0.93 2026-06
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amarin 91.05 88.3 2023-06
AstraZeneca 25.34 4.25 2026-06
BioCryst Pharmaceuticals 6.84 0.78 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
Halozyme Therapeutics 12.51 1.15 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06